Identification of repositionable drugs with novel antimycotic activity by screening the Prestwick Chemical Library against emerging invasive moulds

Hanane Yousfi, Stéphane Ranque, Carole Cassagne, Jean‐Marc Rolain, Fadi Bittar

Journal of Global Antimicrobial Resistance · 2020 · 32 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

OBJECTIVES: The incidence of severe filamentous fungal infections has increased over the past decade. Some of these filamentous fungi are resistant to available antifungals; it is thus urgent to find new compounds that are active against such life-threatening pathogens. METHODS: In this study, 1280 drugs (Prestwick Chemical Library) were tested against six multidrug-resistant (MDR) filamentous fungi, includingAspergillus, Fusarium, Scedosporium/Lomentospora, Rhizopus and Lichtheimia species. RESULTS: Several hits were identified that induced fungal growth inhibition ≥70%. Among the non-antifungal compounds that were effective against the clinical moulds tested in this study, clioquinol, alexidine dihydrochloride, hexachlorophene and thonzonium bromide displayed a broad activity against all strains tested. CONCLUSION: This study enriches the potential antifungal options that can be used against MDR invasive fungal diseases.

References

8